BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19679845)

  • 1. Geography, structure, and evolution of diffusion and perfusion lesions in Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE).
    Olivot JM; Mlynash M; Thijs VN; Purushotham A; Kemp S; Lansberg MG; Wechsler L; Gold GE; Bammer R; Marks MP; Albers GW
    Stroke; 2009 Oct; 40(10):3245-51. PubMed ID: 19679845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diffusion-weighted imaging and perfusion-weighted imaging lesion volumes forecast final infarct size in DEFUSE 2.
    Wheeler HM; Mlynash M; Inoue M; Tipirneni A; Liggins J; Zaharchuk G; Straka M; Kemp S; Bammer R; Lansberg MG; Albers GW;
    Stroke; 2013 Mar; 44(3):681-5. PubMed ID: 23390119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke?
    Rivers CS; Wardlaw JM; Armitage PA; Bastin ME; Carpenter TK; Cvoro V; Hand PJ; Dennis MS
    Stroke; 2006 Jan; 37(1):98-104. PubMed ID: 16322499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.
    Ma L; Gao PY; Hu QM; Lin Y; Jing LN; Xue J; Chen ZJ; Wang YJ; Liu ML; Cai YF
    Neurol Res; 2011 Jun; 33(5):494-502. PubMed ID: 21669118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI.
    Rordorf G; Koroshetz WJ; Copen WA; Cramer SC; Schaefer PW; Budzik RF; Schwamm LH; Buonanno F; Sorensen AG; Gonzalez G
    Stroke; 1998 May; 29(5):939-43. PubMed ID: 9596239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke.
    Neumann-Haefelin T; Wittsack HJ; Wenserski F; Siebler M; Seitz RJ; Mödder U; Freund HJ
    Stroke; 1999 Aug; 30(8):1591-7. PubMed ID: 10436106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLAIR-hyperintense vessel sign, diffusion-perfusion mismatch and infarct growth in acute ischemic stroke without vascular recanalisation therapy.
    Gawlitza M; Gragert J; Quäschling U; Hoffmann KT
    J Neuroradiol; 2014 Oct; 41(4):227-33. PubMed ID: 24507478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total mismatch: negative diffusion-weighted imaging but extensive perfusion defect in acute stroke.
    Cho TH; Hermier M; Alawneh JA; Ritzenthaler T; Desestret V; Østergaard L; Derex L; Baron JC; Nighoghossian N
    Stroke; 2009 Oct; 40(10):3400-2. PubMed ID: 19696413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoperfusion intensity ratio predicts infarct progression and functional outcome in the DEFUSE 2 Cohort.
    Olivot JM; Mlynash M; Inoue M; Marks MP; Wheeler HM; Kemp S; Straka M; Zaharchuk G; Bammer R; Lansberg MG; Albers GW;
    Stroke; 2014 Apr; 45(4):1018-23. PubMed ID: 24595591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining the perfusion-diffusion mismatch hypothesis.
    Butcher KS; Parsons M; MacGregor L; Barber PA; Chalk J; Bladin C; Levi C; Kimber T; Schultz D; Fink J; Tress B; Donnan G; Davis S;
    Stroke; 2005 Jun; 36(6):1153-9. PubMed ID: 15914768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W; Abo M
    Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR.
    Olivot JM; Mlynash M; Thijs VN; Purushotham A; Kemp S; Lansberg MG; Wechsler L; Bammer R; Marks MP; Albers GW
    Stroke; 2009 May; 40(5):1692-7. PubMed ID: 19299632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke: from laboratory to clinics.
    Tatlisumak T; Strbian D; Abo Ramadan U; Li F
    Curr Vasc Pharmacol; 2004 Oct; 2(4):343-55. PubMed ID: 15320814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion- and perfusion-weighted imaging in acute lacunar infarction: is there a mismatch?
    Förster A; Kerl HU; Wenz H; Brockmann MA; Nölte I; Groden C
    PLoS One; 2013; 8(10):e77428. PubMed ID: 24130885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yield of combined perfusion and diffusion MR imaging in hemispheric TIA.
    Mlynash M; Olivot JM; Tong DC; Lansberg MG; Eyngorn I; Kemp S; Moseley ME; Albers GW
    Neurology; 2009 Mar; 72(13):1127-33. PubMed ID: 19092109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between severity of MR perfusion deficit and DWI lesion evolution.
    Thijs VN; Adami A; Neumann-Haefelin T; Moseley ME; Marks MP; Albers GW
    Neurology; 2001 Oct; 57(7):1205-11. PubMed ID: 11591836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis.
    Parsons MW; Christensen S; McElduff P; Levi CR; Butcher KS; De Silva DA; Ebinger M; Barber PA; Bladin C; Donnan GA; Davis SM;
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1214-25. PubMed ID: 20087363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours' duration.
    Schramm P; Schellinger PD; Klotz E; Kallenberg K; Fiebach JB; Külkens S; Heiland S; Knauth M; Sartor K
    Stroke; 2004 Jul; 35(7):1652-8. PubMed ID: 15155964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke.
    Lansberg MG; Thijs VN; Bammer R; Kemp S; Wijman CA; Marks MP; Albers GW;
    Stroke; 2007 Aug; 38(8):2275-8. PubMed ID: 17569874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.